Altimmune (NASDAQ:ALT) is preparing to release its quarterly earnings on Thursday, 2026-03-05. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Altimmune to report an earnings per share (EPS) of $-0.25.
Altimmune bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Overview of Past Earnings
During the last quarter, the company reported an EPS beat by $0.07, leading to a 4.31% increase in the share price on the subsequent day.
Here’s a look at Altimmune’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.32 | -0.35 | -0.34 |
| EPS Actual | -0.21 | -0.27 | -0.26 | -0.33 |
| Price Change % | 4.31 | 3.31 | -1.04 | 3.58 |
Stock Performance
Shares of Altimmune were trading at $4.16 as of March 03. Over the …